ISO 15223-1 Amendment: EC-REP Symbol Changes to EU-REP
The International Organization for Standardization (ISO) has recently amended ISO 15223-1:2021, introducing a change from "EC-REP" to "EU-REP" for the European Authorized Representative symbol.
MedNet EC-REP
Author

This modification aims to eliminate potential confusion with Ecuador's country code (EC) and enhance clarity in medical device labeling. The amendment, ISO 15223-1:2021/Amd 1:2025, specifies that the authorized representative in the European Union will now be identified by "EU-REP" instead of "EC-REP".
Key Points for Manufacturers:
- Gradual Transition: There is no immediate requirement to change your labels. We recommend implementing the new symbol when other label modifications become necessary
- Updated Symbol Usage: When updating your labels, please use our contact details with the new EU-REP symbol
- Notified Body Requirements: If a Notified Body is involved in your product's conformity assessment, they may have specific transition period requirements. We advise contacting them directly for guidance
This amendment reflects the ongoing efforts to streamline and clarify medical device regulations across the European Union. MedNet EC-REP GmbH remains committed to supporting our clients through this transition and ensuring compliance with the latest regulatory standards.
For any questions or concerns regarding this change, please don't hesitate to contact our team. We're here to assist you in navigating these updates and maintaining full compliance with EU regulations.
Related Articles

MDCG 2025-10: New PMS Guidance for MDR & IVDR
The MDCG released new PMS guidance in December 2025. Learn what MDCG 2025-10 means for your MDR and IVDR compliance strategy.

EUDAMED’s first four modules become mandatory on 28 May 2026 - what this means for medical device manufacturers
The European Commission (EC) has formally declared that the first four modules of EUDAMED - the European Database on Medical Devices - will become mandatory as of 28 May 2026.

MHRA Introduces New Device Registration Fee: What Manufacturers Need to Know
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has updated its “DORS Fees Guidance 2.1”, introducing a new annual fee model for device registration.
Stay Updated
Get the latest regulatory updates and industry insights delivered to your inbox.
Subscribe to Updates